Valneva developed a Covid 19 vaccine which the UK has just increased its purchase volumes for.
Valneva SE is a French biotech company based in Saint-Herblain, France, developing and commercializing vaccines for infectious diseases with major unmet needs. Valneva was founded in 2013 through the merger of Intercell and Vivalis SA.